HealthcareNew chief at Bellerophon TherapeuticsSep. 20, 2016 7:01 AM ETBellerophon Therapeutics, Inc. (BLPH) StockBLPHBy: Douglas W. House, SA News Editor Bellerophon Therapeutics (NASDAQ:BLPH) promotes CFO and Chief Business Officer Fabian Tenenbaum to CEO succeeding Jonathan Peacock who will continue to serve as Chairman. Mr. Tenenbaum has been with the firm since February. Recommended For YouMore Trending NewsSee More »About BLPH StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgBLPH--Bellerophon Therapeutics, Inc.Trending AnalysisTrending News